PLA2G1B and chronic obstructive pulmonary disease: Furthermore, in vitro and in vivo experiments validated the regulatory role of PLA2G1B in epithelial cell inflammation, oxidative stress, and apoptosis, thereby elucidating the mechanism underlying CEM in COPD and potentially uncovering novel therapeutic targets for drug development.